Indication
Plasmodium ovale malaria
**Plasmodium ovale malaria** is a mosquito-borne parasitic infection caused by the protozoan parasite *Plasmodium ovale* (encompassing the sympatric subspecies *P. Read more about Plasmodium ovale malaria
37 drugs 36 manufacturers
Drugs that treat it
Common Plasmodium ovale malaria therapies.
PLAQUENIL (hydroxychloroquine sulfate)
HYDROXYCHLOROQUINE SULFATE
HYDROXYCHLOROQUINE SULFATE
HYDROXYCHLOROQUINE SULFATE
HYDROXYCHLOROQUINE SULFATE
HYDROXYCHLOROQUINE SULFATE
HYDROXYCHLOROQUINE SULFATE
SOVUNA (hydroxychloroquine sulfate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon**Plasmodium ovale malaria** is a mosquito-borne parasitic infection caused by the protozoan parasite *Plasmodium ovale* (encompassing the sympatric subspecies *P.
ovale curtisi* and *P.
ovale wallikeri*).
Transmitted through the bites of infective female *Anopheles* mosquitoes, it predominantly affects residents of and travelers to endemic areas, most notably tropical West Africa and parts of the western Pacific.
The infection targets the hepatic and hematologic systems, characterized by the preferential invasion of reticulocytes and young erythrocytes, leading to typical tertian febrile paroxysms occurring every 48 hours, alongside chills, diaphoresis, headache, and fatigue.
A key pathophysiologic hallmark is the parasite's ability to form dormant intrahepatic stages known as hypnozoites, which can reactivate weeks to years after the primary infection to cause clinical relapse unless eradicated.
- nih.gov
**Plasmodium ovale malaria** is a mosquito-borne parasitic infection caused by the protozoan parasite *Plasmodium ovale* (encompassing the sympatric subspecies *P. ovale curtisi* and *P. ovale wallikeri*)
- cdc.gov
**Plasmodium ovale malaria** is a mosquito-borne parasitic infection caused by the protozoan parasite *Plasmodium ovale* (encompassing the sympatric subspecies *P. ovale curtisi* and *P. ovale wallikeri*) Transmitted through the bites of infective female *Anopheles* mosquitoes, it predominantly affects residents of and travelers to endemic areas, most notably tropical West Africa and parts of the western Pacific
- nih.gov
**Plasmodium ovale malaria** is a mosquito-borne parasitic infection caused by the protozoan parasite *Plasmodium ovale* (encompassing the sympatric subspecies *P. ovale curtisi* and *P. ovale wallikeri*) Transmitted through the bites of infective female *Anopheles* mosquitoes, it predominantly affects residents of and travelers to endemic areas, most notably tropical West Africa and parts of the western Pacific
- nih.gov
The infection targets the hepatic and hematologic systems, characterized by the preferential invasion of reticulocytes and young erythrocytes, leading to typical tertian febrile paroxysms occurring every 48 hours, alongside chills, diaphoresis, headache, and fatigue
- nih.gov
The infection targets the hepatic and hematologic systems, characterized by the preferential invasion of reticulocytes and young erythrocytes, leading to typical tertian febrile paroxysms occurring every 48 hours, alongside chills, diaphoresis, headache, and fatigue
- cdc.gov
A key pathophysiologic hallmark is the parasite's ability to form dormant intrahepatic stages known as hypnozoites, which can reactivate weeks to years after the primary infection to cause clinical relapse unless eradicated
- cdc.gov
A key pathophysiologic hallmark is the parasite's ability to form dormant intrahepatic stages known as hypnozoites, which can reactivate weeks to years after the primary infection to cause clinical relapse unless eradicated
Personalize your experience
Follow Plasmodium ovale malaria and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.